Lymphocytic infiltration in multiple sclerosis.
Journal article
Mahla RS., (2024), Mult Scler Relat Disord, 85
Transmembrane domain-driven PD-1 dimers mediate T cell inhibition.
Journal article
Philips EA. et al, (2024), Sci Immunol, 9
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.
Journal article
Grandclément C. et al, (2024), Nat Commun, 15
The protocol of a clinical effectiveness trial comparing standard step up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomised controlled trial
Journal article
WATSON M. et al, (2024), Therapeutic Advances in Musculoskeletal Disease
Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis.
Journal article
Zhao SS. et al, (2024), Rheumatology (Oxford, England), 63, 648 - 656
Clathrin controls bidirectional communication between T cells and antigen presenting cells.
Journal article
Kvalvaag A. and Dustin ML., (2024), Bioessays
CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.
Journal article
Rauber S. et al, (2024), Nat Immunol
Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells
Preprint
Patel A. et al, (2024)
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution.
Journal article
Ng MTH. et al, (2024), Nat Commun, 15
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution
Journal article
DAKIN S., (2024), Nature Communications
Catalyzing change: Implementing standardised reporting in monogenic inflammatory bowel disease research.
Journal article
Yeh P-J. et al, (2024), J Pediatr Gastroenterol Nutr
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Journal article
Cope AP. et al, (2024), Lancet
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial.
Journal article
Jairath V. et al, (2024), BMJ Open Gastroenterol, 11
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Journal article
Lindsay JO. et al, (2024), Lancet Gastroenterol Hepatol
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Journal article
Abhishek A. et al, (2024), Lancet Rheumatol, 6, e92 - e104
The stiffness and collagen control differentiation of osteoclasts with an altered expression of c-Src in podosome
Journal article
Urano K. et al, (2024), Biochemical and Biophysical Research Communications, 149636 - 149636
Vasculitic neuropathy-related disability, pain, quality of life, and autonomic symptoms: A survey of 312 patients.
Journal article
Collins MP. et al, (2024), Rheumatology (Oxford)
Molecular pathogenesis of OA pain: Past, present, and future.
Journal article
Vincent TL. and Miller RE., (2024), Osteoarthritis Cartilage
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study.
Journal article
Mehanna H. et al, (2024), Clin Cancer Res, 30, 356 - 367
The Molecular Signature of Neuropathic Pain in a Human Model System
Preprint
Sandy-Hindmarch OP. et al, (2024)